Lilly goes back to Nimbus for an oral obesity drug in $55M deal
Article Title: Lilly goes back to Nimbus for an oral obesity drug in $55M deal Publication Date: January 6, 2026 In a move that underscores the continued importance of obesity treatment developments in the biotech sector, Lilly has inked a…